Molecular Imaging Market Growth Drivers by 2031
The Molecular Imaging Market is expected to register a CAGR of 9.1% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented by Technology (Gamma Camera, Single Photon Emission Computed Technology, Positron Emission Tomography, Magnetic Resonance Spectroscopy, Optical Imaging, Molecular Ultrasound Imaging). The report further presents analysis based on Application (Cancer, Heart Disease, Brain Disorders, Gastrointestinal Disorders, Lung Disorders, Bone Disorders, Others). Futher, it is segmented based on End User (Hospitals, Diagnostic Imaging Centers, Others). The global analysis is further broken-down at regional level and major countries. The report offers the value in USD for the above analysis and segments.
Purpose of the ReportThe report Molecular Imaging Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Molecular Imaging Market Segmentation
Technology- Gamma Camera
- Single Photon Emission Computed Technology
- Positron Emission Tomography
- Magnetic Resonance Spectroscopy
- Optical Imaging
- Molecular Ultrasound Imaging
- Cancer
- Heart Disease
- Brain Disorders
- Gastrointestinal Disorders
- Lung Disorders
- Bone Disorders
- Others
- Hospitals
- Diagnostic Imaging Centers
- Others
Strategic Insights
Molecular Imaging Market Growth Drivers- Growing Incidence of Cancer: The growing incidence of cancer worldwide is one of the primary growth drivers for this market. Healthcare providers are waiting for more advanced diagnostic techniques to detect tumors at an earlier stage. This is increasing the demand for technologies such as molecular imaging, which provide rich information on metabolic processes and enable timely treatment interventions.
- Technological Innovations: Innovative imaging technologies, PET, SPECT, and MRI, are significantly improving molecular imaging capabilities. Such an advancement results in the development of higher resolution images, enhanced sensitivity, and faster acquisition time, which in turn becomes more effective in diagnosing diseases as well as in monitoring them, thus boosting the demand.
- High Research and Development Activities: In the pharmaceutical and biotech industries, it is through high investment in research and development that the growth of this molecular imaging market will be enabled. The availability of more extended funding for new imaging agents and techniques allows for facilitating innovation in targeted therapies and personalized medicine as well as leading to high-level imaging needs in clinical trials and applications.
- Developing New Imaging Agents: Innovative imaging agents targeting a specific cellular process and biomarker will produce a new horizon of molecular imaging. Such new agents are going to have greater specificity and sensitivity, hence would allow better detection and monitoring of diseases in a much smaller amount of time. This may prove to advance personalized medicine and increase the efficacy of the therapy.
- Hybrid Imaging Technologies are on the Ascent: Hybrid imaging technologies, including combinations of a number of imaging modalities such as PET/CT and PET/MRI, are on the rise. Such systems would provide comprehensive views through functional and anatomical data, hence facilitating better diagnosis and treatment planning. The advancement of hybrid technologies will continue to substantially enhance capabilities in molecular imaging in clinical practice.
- Focus on Point-of-Care Imaging: Molecular imaging solutions that focus on point-of-care diagnostics, particularly at the clinical site, are attracting attention. The systems are portable, and in real-time imaging and bedside decision-making, there is improvement in access and convenience. This focus will be very important for enhancing patient management and outcomes.
- Collaborations with Companies: The collaborations between molecular imaging companies and pharmaceutical companies: Such cooperation can be profitably created with pharmaceutical companies, and it can be developed as very precious opportunities in drug development. Stakeholders can improve the efficacy assessments of drugs and validate most of the biomarkers in the clinical settings that integrate the imaging techniques. It may help in making progress in approaches to targeted therapies and personalized medicines.
- Radiopharmaceuticals Advancements: The future of this market has big opportunities for growth for new radiopharmaceuticals that could be designed to target specific diseases and specific targets. In terms of improved accuracy of diagnosis and monitoring of therapy, this would be much better. Companies that focus their development efforts on innovative radiopharmaceuticals will get an edge from the development toward a constantly increasing radiopharmaceutical market.
- Rising Demand for Early Diagnosis: As early diagnosis and preventive healthcare are gaining emphasis, the scope for molecular imaging will be very strong. With healthcare providers identifying early intervention strategies, the demand for advanced solutions in imaging would increase further to pinpoint diseases at an earlier stage, thus propelling the market growth.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Molecular Imaging Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Molecular Imaging Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The growing incidence of cancer and high research and development activities are the major factors boosting the molecular imaging market growth.
The molecular imaging market is expected to grow at a CAGR of 9.1%.
North America region accounts for highest revenue share in molecular imaging market.
The final report will duly include market size and projection estimates for all the segments from 2021 to 2031, along with a revenue share and compound annual growth rate (%) for the regional/country-wise market wherein 2021-2022 are the historic years, 2023 is considered to be the base year, and the forecast will be provided till 2031, along with CAGR (%).
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2023 - 2031).
Koninklijke Philips, Siemens Healthcare, and Shimadzu Corporation are the major companies operating in the molecular imaging market.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Molecular Imaging Market - By Technology
1.3.2 Molecular Imaging Market - By Application
1.3.3 Molecular Imaging Market - By End User
1.3.4 Molecular Imaging Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. MOLECULAR IMAGING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. MOLECULAR IMAGING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. MOLECULAR IMAGING MARKET - GLOBAL MARKET ANALYSIS
6.1. MOLECULAR IMAGING - GLOBAL MARKET OVERVIEW
6.2. MOLECULAR IMAGING - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. MOLECULAR IMAGING MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. GAMMA CAMERA
7.3.1. Overview
7.3.2. Gamma Camera Market Forecast and Analysis
7.4. SINGLE PHOTON EMISSION COMPUTED TECHNOLOGY
7.4.1. Overview
7.4.2. Single Photon Emission Computed Technology Market Forecast and Analysis
7.5. POSITRON EMISSION TOMOGRAPHY
7.5.1. Overview
7.5.2. Positron Emission Tomography Market Forecast and Analysis
7.6. MAGNETIC RESONANCE SPECTROSCOPY
7.6.1. Overview
7.6.2. Magnetic Resonance Spectroscopy Market Forecast and Analysis
7.7. OPTICAL IMAGING
7.7.1. Overview
7.7.2. Optical Imaging Market Forecast and Analysis
7.8. MOLECULAR ULTRASOUND IMAGING
7.8.1. Overview
7.8.2. Molecular Ultrasound Imaging Market Forecast and Analysis
8. MOLECULAR IMAGING MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CANCER
8.3.1. Overview
8.3.2. Cancer Market Forecast and Analysis
8.4. HEART DISEASE
8.4.1. Overview
8.4.2. Heart Disease Market Forecast and Analysis
8.5. BRAIN DISORDERS
8.5.1. Overview
8.5.2. Brain Disorders Market Forecast and Analysis
8.6. GASTROINTESTINAL DISORDERS
8.6.1. Overview
8.6.2. Gastrointestinal Disorders Market Forecast and Analysis
8.7. LUNG DISORDERS
8.7.1. Overview
8.7.2. Lung Disorders Market Forecast and Analysis
8.8. BONE DISORDERS
8.8.1. Overview
8.8.2. Bone Disorders Market Forecast and Analysis
8.9. OTHERS
8.9.1. Overview
8.9.2. Others Market Forecast and Analysis
9. MOLECULAR IMAGING MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. DIAGNOSTIC IMAGING CENTERS
9.4.1. Overview
9.4.2. Diagnostic Imaging Centers Market Forecast and Analysis
9.5. OTHERS.
9.5.1. Overview
9.5.2. Others. Market Forecast and Analysis
10. MOLECULAR IMAGING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Molecular Imaging Market Overview
10.1.2 North America Molecular Imaging Market Forecasts and Analysis
10.1.3 North America Molecular Imaging Market Forecasts and Analysis - By Technology
10.1.4 North America Molecular Imaging Market Forecasts and Analysis - By Application
10.1.5 North America Molecular Imaging Market Forecasts and Analysis - By End User
10.1.6 North America Molecular Imaging Market Forecasts and Analysis - By Countries
10.1.6.1 United States Molecular Imaging Market
10.1.6.1.1 United States Molecular Imaging Market by Technology
10.1.6.1.2 United States Molecular Imaging Market by Application
10.1.6.1.3 United States Molecular Imaging Market by End User
10.1.6.2 Canada Molecular Imaging Market
10.1.6.2.1 Canada Molecular Imaging Market by Technology
10.1.6.2.2 Canada Molecular Imaging Market by Application
10.1.6.2.3 Canada Molecular Imaging Market by End User
10.1.6.3 Mexico Molecular Imaging Market
10.1.6.3.1 Mexico Molecular Imaging Market by Technology
10.1.6.3.2 Mexico Molecular Imaging Market by Application
10.1.6.3.3 Mexico Molecular Imaging Market by End User
10.2. EUROPE
10.2.1 Europe Molecular Imaging Market Overview
10.2.2 Europe Molecular Imaging Market Forecasts and Analysis
10.2.3 Europe Molecular Imaging Market Forecasts and Analysis - By Technology
10.2.4 Europe Molecular Imaging Market Forecasts and Analysis - By Application
10.2.5 Europe Molecular Imaging Market Forecasts and Analysis - By End User
10.2.6 Europe Molecular Imaging Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Molecular Imaging Market
10.2.6.1.1 Germany Molecular Imaging Market by Technology
10.2.6.1.2 Germany Molecular Imaging Market by Application
10.2.6.1.3 Germany Molecular Imaging Market by End User
10.2.6.2 France Molecular Imaging Market
10.2.6.2.1 France Molecular Imaging Market by Technology
10.2.6.2.2 France Molecular Imaging Market by Application
10.2.6.2.3 France Molecular Imaging Market by End User
10.2.6.3 Italy Molecular Imaging Market
10.2.6.3.1 Italy Molecular Imaging Market by Technology
10.2.6.3.2 Italy Molecular Imaging Market by Application
10.2.6.3.3 Italy Molecular Imaging Market by End User
10.2.6.4 Spain Molecular Imaging Market
10.2.6.4.1 Spain Molecular Imaging Market by Technology
10.2.6.4.2 Spain Molecular Imaging Market by Application
10.2.6.4.3 Spain Molecular Imaging Market by End User
10.2.6.5 United Kingdom Molecular Imaging Market
10.2.6.5.1 United Kingdom Molecular Imaging Market by Technology
10.2.6.5.2 United Kingdom Molecular Imaging Market by Application
10.2.6.5.3 United Kingdom Molecular Imaging Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Molecular Imaging Market Overview
10.3.2 Asia-Pacific Molecular Imaging Market Forecasts and Analysis
10.3.3 Asia-Pacific Molecular Imaging Market Forecasts and Analysis - By Technology
10.3.4 Asia-Pacific Molecular Imaging Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Molecular Imaging Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Molecular Imaging Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Molecular Imaging Market
10.3.6.1.1 Australia Molecular Imaging Market by Technology
10.3.6.1.2 Australia Molecular Imaging Market by Application
10.3.6.1.3 Australia Molecular Imaging Market by End User
10.3.6.2 China Molecular Imaging Market
10.3.6.2.1 China Molecular Imaging Market by Technology
10.3.6.2.2 China Molecular Imaging Market by Application
10.3.6.2.3 China Molecular Imaging Market by End User
10.3.6.3 India Molecular Imaging Market
10.3.6.3.1 India Molecular Imaging Market by Technology
10.3.6.3.2 India Molecular Imaging Market by Application
10.3.6.3.3 India Molecular Imaging Market by End User
10.3.6.4 Japan Molecular Imaging Market
10.3.6.4.1 Japan Molecular Imaging Market by Technology
10.3.6.4.2 Japan Molecular Imaging Market by Application
10.3.6.4.3 Japan Molecular Imaging Market by End User
10.3.6.5 South Korea Molecular Imaging Market
10.3.6.5.1 South Korea Molecular Imaging Market by Technology
10.3.6.5.2 South Korea Molecular Imaging Market by Application
10.3.6.5.3 South Korea Molecular Imaging Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Molecular Imaging Market Overview
10.4.2 Middle East and Africa Molecular Imaging Market Forecasts and Analysis
10.4.3 Middle East and Africa Molecular Imaging Market Forecasts and Analysis - By Technology
10.4.4 Middle East and Africa Molecular Imaging Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Molecular Imaging Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Molecular Imaging Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Molecular Imaging Market
10.4.6.1.1 South Africa Molecular Imaging Market by Technology
10.4.6.1.2 South Africa Molecular Imaging Market by Application
10.4.6.1.3 South Africa Molecular Imaging Market by End User
10.4.6.2 Saudi Arabia Molecular Imaging Market
10.4.6.2.1 Saudi Arabia Molecular Imaging Market by Technology
10.4.6.2.2 Saudi Arabia Molecular Imaging Market by Application
10.4.6.2.3 Saudi Arabia Molecular Imaging Market by End User
10.4.6.3 U.A.E Molecular Imaging Market
10.4.6.3.1 U.A.E Molecular Imaging Market by Technology
10.4.6.3.2 U.A.E Molecular Imaging Market by Application
10.4.6.3.3 U.A.E Molecular Imaging Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Molecular Imaging Market Overview
10.5.2 South and Central America Molecular Imaging Market Forecasts and Analysis
10.5.3 South and Central America Molecular Imaging Market Forecasts and Analysis - By Technology
10.5.4 South and Central America Molecular Imaging Market Forecasts and Analysis - By Application
10.5.5 South and Central America Molecular Imaging Market Forecasts and Analysis - By End User
10.5.6 South and Central America Molecular Imaging Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Molecular Imaging Market
10.5.6.1.1 Brazil Molecular Imaging Market by Technology
10.5.6.1.2 Brazil Molecular Imaging Market by Application
10.5.6.1.3 Brazil Molecular Imaging Market by End User
10.5.6.2 Argentina Molecular Imaging Market
10.5.6.2.1 Argentina Molecular Imaging Market by Technology
10.5.6.2.2 Argentina Molecular Imaging Market by Application
10.5.6.2.3 Argentina Molecular Imaging Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. MOLECULAR IMAGING MARKET, KEY COMPANY PROFILES
12.1. GENERAL ELECTRIC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. KONINKLIJKE PHILIPS N.V
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. SIEMENS HEALTHCARE PRIVATE LIMITED
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. SHIMADZU CORPORATION
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. HITACHI HIGH-TECHNOLOGIES CORPORATION
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ESAOTE SPA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BRUKER
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. CANON MEDICAL SYSTEMS CORPORATION
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. FUJIFILM HOLDINGS CORPORATION
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. CARESTREAM HEALTH
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
- General Electric
- Koninklijke Philips N.V
- Siemens Healthcare Private Limited
- Shimadzu Corporation
- Hitachi High-Technologies Corporation
- ESAOTE SPA
- Bruker
- CANON MEDICAL SYSTEMS CORPORATION
- Fujifilm Holdings Corporation
- Carestream Health
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For